Skip to the page

Data / Form D filings / Spiral Therapeutics Inc

Spiral Therapeutics Inc: Form D filings

Spiral Therapeutics Inc, a pharmaceuticals company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2018 and 2026. The latest, on April 16, 2026, reports $27.1 million sold of a $27.1 million offering to 34 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6000 SHORELINE COURT SUITE 206, South San Francisco, CA, 94080
Phone
(650) 453-0893
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1761906

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 16, 2026New notice$27,089,842$27,089,839$334Sep 30, 2025sec.gov
Feb 7, 2023Amendment$10,904,985$10,904,98548Oct 18, 2022sec.gov
Dec 2, 2022New notice$8,245,175$1,265,343$6,979,83212Oct 18, 2022sec.gov
Dec 19, 2018New notice$12,944,560$8,474,654$4,469,90638Dec 10, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
HUGO PERISExecutive Officer, Director
ANTHONY ADAMISDirector
EUGENE DE JUANExecutive Officer, Director
GUY JEAN SAVOIR GARCIADirector
ANGELA MACFARLANEDirector
FREDERIC GUERARDDirector
DIAMANTIS XYLASDirector
JEAN-FREDERIC PAULSENDirector
WARREN THALERDirector

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Apr 13, 2026 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Spiral Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.